FREDUN PHARMACEUTICALS
|
FREDUN PHARMACEUTICALS Last 5 Year Cashflow Statement History
[Consolidated]
| Mar2026 | Mar2025 | |
|---|---|---|
| Profit Before Tax | ₹35 Cr | ₹27 Cr |
| Adjustment | ₹46 Cr | ₹28 Cr |
| Changes In working Capital | ₹-69 Cr | ₹-72 Cr |
| Cash Flow after changes in Working Capital | ₹12 Cr | ₹-17 Cr |
| Cash Flow from Operating Activities | ₹12 Cr | ₹-17 Cr |
| Cash Flow from Investing Activities | ₹-74 Cr | ₹-6.35 Cr |
| Cash Flow from Financing Activities | ₹121 Cr | ₹27 Cr |
| Net Cash Inflow / Outflow | ₹60 Cr | ₹3.70 Cr |
| Opening Cash & Cash Equivalents | ₹5.22 Cr | ₹1.52 Cr |
| Cash & Cash Equivalent on Amalgamation / Take over / Merger | - | - |
| Cash & Cash Equivalent of Subsidiaries under liquidations | - | - |
| Translation adjustment on reserves / op cash balalces frgn subsidiaries | - | - |
| Effect of Foreign Exchange Fluctuations | - | - |
| Closing Cash & Cash Equivalent | ₹65 Cr | ₹5.22 Cr |
Compare Cashflow Statement of peers of FREDUN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| FREDUN PHARMACEUTICALS | ₹1,438.5 Cr | 13.2% | 10.6% | 226.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹437,639.0 Cr | 0.9% | -3.1% | 7.9% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,647.0 Cr | 2% | -2.1% | -0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹150,366.0 Cr | -2.9% | -0.3% | 36.4% | Stock Analytics | |
| CIPLA | ₹109,528.0 Cr | -2.4% | -3.8% | -10.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹105,819.0 Cr | -0.5% | -5% | -6.9% | Stock Analytics | |
FREDUN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| FREDUN PHARMACEUTICALS | 13.2% |
10.6% |
226.5% |
| SENSEX | 4.9% |
2.8% |
-6.2% |
You may also like the below Video Courses